We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Guangzhou Pluslife Biotech Co., Ltd.

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Surge in Adoption of Next-Gen Non-Invasive DNA Tests for High-Risk Pregnancies to Drive NIPT Market

By LabMedica International staff writers
Posted on 07 Oct 2022
Print article
Image: The global NIPT market is projected to surpass USD 8 billion by the end of 2031 (Photo courtesy of Pexels)
Image: The global NIPT market is projected to surpass USD 8 billion by the end of 2031 (Photo courtesy of Pexels)

The global non-invasive prenatal testing (NIPT) market is projected to register a CAGR of 14.8% between 2022 and 2031 to reach USD 8.4 billion by the end of 2031, driven by an increase in the prevalence of Turners' syndrome and Down's syndrome among newborn babies, as well as a surge in the adoption of next-gen non-invasive DNA tests in high-risk pregnancies.

These are the latest findings of Transparency Market Research (Wilmington, DE, USA), a global market research company.

There has been a rise in cases of Down's syndrome and Turners' syndrome among newborn babies globally which is driving demand in the NIPT market. The popularity of NIPT has been increasing in recent years owing to the ability of this procedure to provide precise test results within a short duration. As a result, the growing adoption of testing is creating lucrative growth prospects for the NIPT market.

Additionally, governments in several countries are implementing favorable policies to provide complete reimbursement of NIPT in the second trimester, resulting in a rise in the adoption of such tests. Moreover, regulatory authorities in several countries are focusing on offering reimbursement for different tests, including non-invasive prenatal tests for chromosomal health issues such as Down's syndrome. These efforts are expected to drive sales of the global NIPT market.

Going forward, growing preference among healthcare professionals for performing next-gen non-invasive DNA tests for high-risk pregnancies is expected to drive sales of the NIPT market. Further, the increasing trend of delaying pregnancy among couples is anticipated to fuel market growth. Also, a surge in the prevalence of pregnancy-related problems in the second or third trimester is likely to contribute to the market growth.

Geographically, the North American NIPT market is anticipated to register the strongest growth during the forecast period owing to an increase in diagnosis and treatment of trisomy health issues, the presence of several key players, and existence of a well-established healthcare infrastructure in the U.S. The Asia Pacific NIPT market is expected to expand at a fast pace due to an increase in maternal age in the region, which can lead to a rise in cases of chromosomal aneuploidies among babies.

Related Links:
Transparency Market Research 

Gold Supplier
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Rapid Immunological FOB Test
Fecal Occult Blood Test
Nucleic Acid Extractor
Hepatitis B IgM ELISA

Print article


Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more


view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more


view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.